Juergen Froehlich
Direttore Tecnico/Scientifico/R&S presso ARCTURUS THERAPEUTICS HOLDINGS INC.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Juergen Froehlich
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| APPILI THERAPEUTICS INC. | Direttore/Membro del Consiglio | 27/01/2020 | - |
| Independent Dir/Board Member | 27/01/2020 | - | |
| SPEXIS AG | Direttore Tecnico/Scientifico/R&S | 30/12/2021 | - |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Direttore Tecnico/Scientifico/R&S | - | - |
| Vendite & Marketing | 01/03/2023 | - |
Storia della carriera di Juergen Froehlich
Precedenti posizioni note di Juergen Froehlich
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Vendite & Marketing | 01/01/2022 | 01/04/2023 |
| ARADIGM CORPORATION | Direttore Tecnico/Scientifico/R&S | 31/05/2018 | 14/02/2019 |
| ARADIGM CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/11/2013 | 11/02/2018 |
| Consigliere Generale | 01/11/2013 | 11/02/2018 | |
| VERTEX PHARMACEUTICALS INCORPORATED | Consigliere Generale | 01/10/2011 | 01/09/2013 |
Formazione di Juergen Froehlich
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
| State University of New York at Albany | Masters Business Admin |
| Graduate School of Business Administration Zürich | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Svizzera | 3 |
| Germania | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| General Counsel | 2 |
| Masters Business Admin | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 4 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| APPILI THERAPEUTICS INC. | Health Technology |
| SPEXIS AG | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Aziende private | 2 |
|---|---|
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Health Services |
- Borsa valori
- Insiders
- Juergen Froehlich
- Esperienza
